CN100408591C - 嘧啶核苷衍生物的晶形 - Google Patents
嘧啶核苷衍生物的晶形 Download PDFInfo
- Publication number
- CN100408591C CN100408591C CNB028079337A CN02807933A CN100408591C CN 100408591 C CN100408591 C CN 100408591C CN B028079337 A CNB028079337 A CN B028079337A CN 02807933 A CN02807933 A CN 02807933A CN 100408591 C CN100408591 C CN 100408591C
- Authority
- CN
- China
- Prior art keywords
- crystal
- compound
- crystalline form
- obtains
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33128/2001 | 2001-02-09 | ||
| JP2001033128 | 2001-02-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1501939A CN1501939A (zh) | 2004-06-02 |
| CN100408591C true CN100408591C (zh) | 2008-08-06 |
Family
ID=18896929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB028079337A Expired - Lifetime CN100408591C (zh) | 2001-02-09 | 2002-02-06 | 嘧啶核苷衍生物的晶形 |
Country Status (21)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2081419B1 (en) | 1999-09-02 | 2013-08-07 | Ibiden Co., Ltd. | Printed circuit board and method of manufacturing printed circuit board |
| CN101232776B (zh) | 1999-09-02 | 2011-04-20 | 揖斐电株式会社 | 印刷布线板 |
| GB0526419D0 (en) | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| JP5066737B2 (ja) * | 2007-04-06 | 2012-11-07 | 大鵬薬品工業株式会社 | シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤 |
| US8124593B2 (en) | 2007-11-05 | 2012-02-28 | Cyclacel Limited | Methods of treatment using sapacitabine |
| GB0808357D0 (en) * | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
| PL2307002T3 (pl) | 2008-06-09 | 2013-05-31 | Cyclacel Ltd | Kombinacje sapacytabiny lub cndac z inhibitorami metylotransferazy dna, takimi jak decytabina i prokaina |
| PL2696878T3 (pl) | 2011-04-14 | 2020-01-31 | Cyclacel Limited | Schemat dawkowania dla sapacytabiny i decytabiny w kombinacji do leczenia ostrej białaczki szpikowej |
| ES2880109T3 (es) | 2012-03-15 | 2021-11-23 | Celgene Car Llc | Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico |
| ES2963057T3 (es) * | 2015-03-09 | 2024-03-25 | Grace W R & Co | Forma cristalina de ribósido de nicotinamida |
| EP3727400A4 (en) | 2017-12-22 | 2021-10-20 | Elysium Health, Inc. | CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1072686A (zh) * | 1991-09-30 | 1993-06-02 | 三共株式会社 | 具有抗肿瘤活性的嘧啶核苷衍生物及其制备方法和用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
-
2002
- 2002-02-04 JP JP2002026232A patent/JP3748536B2/ja not_active Expired - Lifetime
- 2002-02-06 CN CNB028079337A patent/CN100408591C/zh not_active Expired - Lifetime
- 2002-02-06 EP EP02711347A patent/EP1364959B1/en not_active Expired - Lifetime
- 2002-02-06 KR KR1020037010308A patent/KR100679904B1/ko not_active Expired - Lifetime
- 2002-02-06 CZ CZ20032111A patent/CZ303241B6/cs not_active IP Right Cessation
- 2002-02-06 DK DK02711347T patent/DK1364959T3/da active
- 2002-02-06 AU AU2002230164A patent/AU2002230164B2/en not_active Expired
- 2002-02-06 PT PT02711347T patent/PT1364959E/pt unknown
- 2002-02-06 BR BRPI0207102A patent/BRPI0207102A8/pt unknown
- 2002-02-06 IL IL15721602A patent/IL157216A0/xx active IP Right Grant
- 2002-02-06 MX MXPA03007123A patent/MXPA03007123A/es active IP Right Grant
- 2002-02-06 WO PCT/JP2002/000986 patent/WO2002064609A1/ja not_active Ceased
- 2002-02-06 BR BR0207102-9A patent/BR0207102A/pt not_active Application Discontinuation
- 2002-02-06 NZ NZ527393A patent/NZ527393A/en not_active IP Right Cessation
- 2002-02-06 HU HU0303159A patent/HU229294B1/hu unknown
- 2002-02-06 DE DE60220024T patent/DE60220024T2/de not_active Expired - Lifetime
- 2002-02-06 AT AT02711347T patent/ATE361929T1/de active
- 2002-02-06 ES ES02711347T patent/ES2286237T3/es not_active Expired - Lifetime
- 2002-02-06 CA CA2437994A patent/CA2437994C/en not_active Expired - Lifetime
- 2002-02-06 RU RU2003124648/04A patent/RU2256666C2/ru active
-
2003
- 2003-08-04 IL IL157216A patent/IL157216A/en unknown
- 2003-08-07 ZA ZA2003/06121A patent/ZA200306121B/en unknown
-
2005
- 2005-08-09 JP JP2005230800A patent/JP4356998B2/ja not_active Expired - Lifetime
-
2007
- 2007-07-02 CY CY20071100860T patent/CY1106685T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1072686A (zh) * | 1991-09-30 | 1993-06-02 | 三共株式会社 | 具有抗肿瘤活性的嘧啶核苷衍生物及其制备方法和用途 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4484438A1 (en) | POLYMORPHIC FORM OF REDUCED ß-NICOTINAMIDE MONONUCLEOTIDE DISODIUM SALT, AND PREPARATION METHOD THEREFOR AND USE THEREOF | |
| CN107531646B (zh) | 尿嘧啶化合物的结晶 | |
| KR20010099806A (ko) | 아지트로마이신의 에탄올레이트, 이것의 제조 방법 및약학 조성물 | |
| CN101597272B (zh) | 艾拉莫德的钾盐化合物,其制备方法和药物应用 | |
| CN1501939A (zh) | 嘧啶核苷衍生物的晶体 | |
| US20240350501A1 (en) | SALT OF N-(2,6-DIETHYLPHENYL)-8-({4-[4-(DIMETHYLAMINO) PIPERIDIN-1-YL]-2-METHOXYPHENYL}AMINO)-1-METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-h]QUINAZOLINE-3-CARBOXAMIDE, ITS PREPARATION, AND FORMULATIONS CONTAINING IT | |
| WO2024248083A1 (ja) | キノリン置換化合物の結晶 | |
| WO2022228578A1 (en) | Pyrimidinylaminobenzenes for lung cancer treatment | |
| CN118290384B (zh) | 大豆苷元与哌嗪共晶物及制备方法和其组合物与用途 | |
| WO2021139797A1 (zh) | 恩曲替尼晶型及其制备方法 | |
| CN1324354A (zh) | 玻璃状己知缓激肽拮抗剂 | |
| CN101665449A (zh) | 他米巴罗汀的水溶性前药及其制备方法与应用 | |
| CN118359591A (zh) | 一种化合物与氨基酸的固体形式及其制备方法和用途 | |
| JP2025527161A (ja) | 置換されたピラゾロ[1,5-a]ピリミジン-7-アミン誘導体の薬学的に許容される塩および多形体、ならびにその使用 | |
| AU732408B2 (en) | Nucleosides | |
| CN109846873B (zh) | 一种抗肿瘤药物组合物 | |
| CN104098575B (zh) | 一种盐酸依匹斯汀晶型及其制备方法和用途 | |
| CN113801021A (zh) | 绿原酸钠水合物及其应用 | |
| CN110642854A (zh) | 一种稠环化合物的多晶型、其组合物、制备方法及其应用 | |
| CN117263982B (zh) | 含氮芳基磷氧化物衍生物的晶型及其制备方法和应用 | |
| CN109528664B (zh) | 含乌苯美司-抗肿瘤药物协同前药衍生物的冻干粉剂及其制备方法 | |
| CN114276329B (zh) | 喹啉化合物的盐的晶型及其制备方法和应用 | |
| CN112047990B (zh) | 阿糖胞苷前药mb07133晶型及其应用 | |
| TW202606690A (zh) | 吡啶并吡唑衍生物的晶型物、藥物組合物及其用途 | |
| EP4234557A1 (en) | Salt of nucleoside analog and crystal form thereof, pharmaceutical composition and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term |
Granted publication date: 20080806 |
|
| CX01 | Expiry of patent term |